Acurx increases authorized common stock from 200 million to 250 million shares

Acurx Pharmaceuticals, Inc.

Stockholders approved amendment at special meeting on September 16, 2025.
Authorized common stock increased from 200,000,000 to 250,000,000 shares.
Amendment filed with Delaware Secretary of State on September 22, 2025, effective immediately.
Shares may be used for future capital raising, acquisitions, or other corporate purposes.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.